U.S. Markets closed

Free Research Reports on Nutrien and Three More Agricultural Chemicals Stocks

Stock Research Monitor: RKDA, SMG, and SNES

LONDON, UK / ACCESSWIRE / July 26, 2018 / If you want a free Stock Review on NTR sign up now at www.wallstequities.com/registration. This morning, WallStEquities.com recalls the recent performance of Nutrien Ltd (NYSE: NTR), Arcadia Biosciences Inc. (NASDAQ: RKDA), The Scotts Miracle-Gro Co. (NYSE: SMG), and SenesTech Inc. (NASDAQ: SNES). Companies in the Agricultural Chemicals industry produce much of agriculture's applied research and maintains the database of agricultural technical and scientific knowledge. All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Nutrien

On Wednesday, shares in Saskatoon, Canada headquartered Nutrien Ltd recorded a trading volume of 1.10 million shares. The stock ended the session 0.88% higher at $52.96. The Company's shares have gained 14.26% over the previous three months. The stock is trading 0.88% above its 50-day moving average and 5.49% above its 200-day moving average. Moreover, shares of Nutrien, which produces and markets crop nutrients worldwide, have a Relative Strength Index (RSI) of 51.99.

On July 23rd, 2018, Nutrien announced that it has entered into a definitive agreement with SDIC Mining Investment Co. Ltd to sell 23,294,614 common shares of Arab Potash Company (APC) for gross proceeds of $502 million. The announced transaction represents the entirety of Nutrien's holdings in APC. Get the full research report on NTR for free by clicking below at:

www.wallstequities.com/registration/?symbol=NTR

Arcadia Biosciences

Davis, California headquartered Arcadia Biosciences Inc.'s stock closed the day 1.70% higher at $7.19 with a total trading volume of 173,268 shares. The stock is trading 19.55% below 50-day moving average. Shares of the Company, which develops and commercializes health and nutrition ingredient traits worldwide, has an RSI of 39.29.

On July 11th, 2018, Arcadia Biosciences and Bioceres S.A. announced that they have hired Martin Mariani Ventura as general manager of Verdeca, a joint venture to develop, deregulate and market soybean varieties with next generation agricultural technologies. Mr. Ventura is a seasoned agribusiness executive with nearly 20 years of experience in various roles, including business strategy, product licensing and commercialization, sales, marketing, and research and development. Today's complimentary research report on RKDA is accessible at:

www.wallstequities.com/registration/?symbol=RKDA

Scotts Miracle-Gro

Shares in Marysville, Ohio headquartered The Scotts Miracle-Gro Co. recorded a trading volume of 471,676 shares. The stock ended yesterday's trading session 0.51% higher at $80.49. The Company's shares are trading below their 50-day moving average by 4.50%. Furthermore, shares of Scotts Miracle-Gro, which manufactures, markets, and sells consumer lawn and garden products, have an RSI of 37.11.

On July 10th, 2018, Scotts Miracle-Gro announced that it will release its Q3 financial results on July 31st, 2018, following the closing of the US financial markets. The Company will host a conference call at 4:30 p.m. ET that same day to discuss the results. A live webcast of the call and the press release will be available on Company's investor relations website. Sign up for free on Wall St. Equities and claim the latest report on SMG at:

www.wallstequities.com/registration/?symbol=SMG

SenesTech

Flagstaff, Arizona headquartered SenesTech Inc.'s stock finished Wednesday's session 4.35% lower at $1.32 with a total trading volume of 868,362 shares. The Company's shares have surged 193.33% over the previous three months. The stock is trading above its 200-day moving average by 22.83%. Additionally, shares of SenesTech, which develops a technology for managing animal pest populations through fertility control, have an RSI of 41.48.

On July 19th, 2018, SenesTech announced the sale of ContraPest® to Pestmaster Services® ("Pestmaster") for the first deployment in California. Pestmaster plans to immediately deploy ContraPest to new and existing customers who have been pre-selected for it. The order also includes stocking quantities for additional customers yet to be identified. See the free research coverage on SNES at:

www.wallstequities.com/registration/?symbol=SNES

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483

Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities